Latest Breaking News On - Psych congress elevate - Page 1 : comparemela.com

New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)

Switching to UZEDY at four weeks after the last dose of once-monthly paliperidone palmitate provided the most comparable pharmacokinetic profile based on the relevant PK modeling data Additional.

Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024

Nearly 98% of patients experience quality of life impact as a result of tardive dyskinesia including social, psychological, physical and recreational aspects of daily living Data highlight for.

Alkermes plc: Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences

HMP Global Announces Landmark Acquisition of Neuroscience Education Institute (NEI)

/PRNewswire/ HMP Global, a leading omnichannel healthcare education and events company, today announced it has entered into a definitive agreement to.

Renowned schizophrenia authority Dr. Peter Weiden joins HMP Global's Psych Congress as educational consultant